Israeli stent company InspireMD raises up to USD113 million
Categories: Banking & Finance, Hi-Tech
Israeli stent company, InspireMD has raised up to USD113 million as it looks to utilize its proprietary MicroNet technology to make its products the industry standard for carotid stenting.
Greenberg Traurig advised the company, which is based in the U.S. and Israel, on the financing led by the LifeSci investment bank, with participation from Marshall Wace, OrbiMed, Rosalind, Nantahala, Soleus, Velan and certain InspireMD Board members.